Snehal Patel
Fortune : 147 M $ au 31/05/2026
Fortune : 147 M $ au 31/05/2026
Snehal S.
Patel is currently Director, Chief Executive & Financial Officer at Greenwich LifeSciences, Inc. since 2016 and has been with the company since 2010.
Mr. Patel is also VP-Operations at Welspun Corp.
Ltd. Education includes an undergraduate degree from Massachusetts Institute of Technology and an MBA from The University of Chicago.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/05/2026 | 5 604 102 ( 40,45% ) | 147 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| GREENWICH LIFESCIENCES, INC. | Directeur Général | 01/06/2016 |
| WELSPUN CORP LIMITED | Directeur des opérations | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Welspun Corp. Ltd.
Welspun Corp. Ltd. Industrial MachineryProducer Manufacturing Manufactures steel pipes, coils and plates | Producer Manufacturing |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Greenwich LifeSciences, Inc.
Greenwich LifeSciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapy to prevent breast cancer recurrences | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national